{"id":892572,"title":"Analysis of the SARS-CoV-2 main protease and presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants, CCDR 50(10) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T02:04:59.854000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/analysis-sars-cov-2-main-protease-presence-nirmatrelvir-resistant-omicron-mutants.html","snippet":"Analysis of the SARS-CoV-2 main protease and presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants Download this article as a PDF (206 KB) Published by: The Public Health Agency of Canada Issue: CCDR Volume 50-10, October 2024: COVID-19 after the pandemic Date published:…","rawSnapshotUrl":"/api/snapshots/raw/892572","browseUrl":"https://replay.healtharchive.ca/job-7/20260306020459/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-10-october-2024/analysis-sars-cov-2-main-protease-presence-nirmatrelvir-resistant-omicron-mutants.html#ha_snapshot=892572","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}